Metabolomic Insights into Prostate Cancer Treatment and Relapse
Kristina Lundquist, Henrik Antti, Camilla Thellenberg Karlsson, Laura S Schmidt · 2025
Read Metabolomic Insights into Prostate Cancer Treatment and Relapse by Kristina Lundquist, Henrik Antti, Camilla Thellenberg Karlsson, Laura S Schmidt (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12730953.txt.
Description
Kristina Lundquist and co-authors track small molecules in blood to read how prostate cancer treatment is going, in a 2025 study. Men with high-risk disease often get hormone therapy plus radiation. Blood markers that flag who will relapse could let doctors tailor that care.
They study 136 blood samples from 35 patients, drawn before, between, and after the two treatments. Hormone therapy drove most of the chemical change, with steroids and fatty acids shifting most. Radiation added less. Comparing men who relapsed with those who did not, the team find telling gaps in molecules such as cholesterol and a steroid byproduct. The patterns are early leads, and the authors call for larger studies to turn them into tests.
Catalog record
| CREATOR | Kristina Lundquist, Henrik Antti, Camilla Thellenberg Karlsson, Laura S Schmidt |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |